JDVRX
Price
$22.20
Change
+$0.26 (+1.19%)
Updated
Dec 20 closing price
RMFCX
Price
$54.73
Change
+$0.55 (+1.02%)
Updated
Dec 20 closing price
Ad is loading...

JDVRX vs RMFCX

Header iconJDVRX vs RMFCX Comparison
Open Charts JDVRX vs RMFCXBanner chart's image
PGIM Jennison Value R
Price$22.20
Change+$0.26 (+1.19%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.73
Change+$0.55 (+1.02%)
VolumeN/A
CapitalizationN/A
JDVRX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JDVRX vs. RMFCX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDVRX is a Buy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 102B vs. JDVRX (618M). RMFCX pays higher dividends than JDVRX: RMFCX (1.69) vs JDVRX (0.75). JDVRX was incepted earlier than RMFCX: JDVRX (20 years) vs RMFCX (23 years). JDVRX is a more actively managed with annual turnover of: 28.00 vs. RMFCX (25.00). JDVRX has a lower initial minimum investment than RMFCX: JDVRX (0) vs RMFCX (250). JDVRX annual gain was more profitable for investors over the last year : 14.09 vs. RMFCX (11.11). RMFCX return over 5 years is better than : 37.80 vs. JDVRX (21.25).
JDVRXRMFCXJDVRX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years23 years-
Gain YTD12.9479.921131%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets618M102B1%
Annual Yield % from dividends0.751.6944%
Returns for 1 year14.0911.11127%
Returns for 3 years5.2012.3842%
Returns for 5 years21.2537.8056%
Returns for 10 years11.8359.3620%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QURE16.981.51
+9.76%
uniQure NV
HAYW15.440.10
+0.65%
Hayward Holdings
TER125.950.76
+0.61%
Teradyne
ISPO3.36-0.06
-1.75%
Inspirato
ADCT1.96-0.16
-7.55%
ADC Therapeutics SA